Εμφάνιση απλής εγγραφής

dc.creatorSakkas L.I., Daoussis D., Mavropoulos A., Liossis S.-N., Bogdanos D.P.en
dc.date.accessioned2023-01-31T09:53:19Z
dc.date.available2023-01-31T09:53:19Z
dc.date.issued2019
dc.identifier10.1016/j.semarthrit.2018.10.007
dc.identifier.issn00490172
dc.identifier.urihttp://hdl.handle.net/11615/78727
dc.description.abstractObjective: Regulatory B cells (Bregs) are a new subset of B cells with immunoregulatory functions, mainly through IL-10 production. Bregs suppress inflammatory Th1 and Th17 differentiation and induce Tregs suppressing autoimmune diseases. The aim of the study was to review the literature related to Bregs in autoimmune rheumatic diseases (ARDs). Methods: A literature review of publications in PUBMED published in English was performed using the relevant combinations of terms. Results: All relevant publications are discussed. Overall, recent studies in rheumatic diseases found Bregs to be decreased in ANCA-associated vasculitides (AAV) and in systemic sclerosis (SSc), particularly in SSc-associated lung fibrosis. In AAV Bregs levels are negatively correlated with autoantibody levels whereas in SSc this association is less clear but there is an inverse association with Th1 and Th17 cells. In rheumatoid arthritis (RA), Bregs were decreased, particularly in RA-associated lung fibrosis. In psoriatic arthritis IL-10 + Bregs are decreased and inversely associated with Th1 and Th17 cells. In systemic lupus erythematosus (SLE), the role of Bregs is unclear. In experimental diseases, when Bregs were expanded ex-vivo, they ameliorated established disease. Conclusion: Bregs appear to be a new player in the pathogenesis of ARDs, and may offer a new strategy for therapeutic intervention. © 2018 Elsevier Inc.en
dc.language.isoenen
dc.sourceSeminars in Arthritis and Rheumatismen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85055990350&doi=10.1016%2fj.semarthrit.2018.10.007&partnerID=40&md5=330b3f351a3dd4ce65967486402cf839
dc.subjectautoantibodyen
dc.subjectinterleukin 10en
dc.subjectanaphylactoid purpuraen
dc.subjectANCA associated vasculitisen
dc.subjectankylosing spondylitisen
dc.subjectautoimmune diseaseen
dc.subjectdisease associationen
dc.subjectex vivo studyen
dc.subjectgiant cell arteritisen
dc.subjecthumanen
dc.subjectinflammatory bowel diseaseen
dc.subjectinflammatory diseaseen
dc.subjectlung fibrosisen
dc.subjectnonhumanen
dc.subjectpathogenesisen
dc.subjectpriority journalen
dc.subjectpsoriatic arthritisen
dc.subjectreactive arthritisen
dc.subjectregulatory B lymphocyteen
dc.subjectReviewen
dc.subjectrheumatic diseaseen
dc.subjectrheumatoid arthritisen
dc.subjectSjoegren syndromeen
dc.subjectspondylarthritisen
dc.subjectsystematic reviewen
dc.subjectsystemic lupus erythematosusen
dc.subjectsystemic sclerosisen
dc.subjectTh1 cellen
dc.subjectTh17 cellen
dc.subjectautoimmune diseaseen
dc.subjectimmunologyen
dc.subjectinflammationen
dc.subjectregulatory B lymphocyteen
dc.subjectrheumatic diseaseen
dc.subjectAutoimmune Diseasesen
dc.subjectB-Lymphocytes, Regulatoryen
dc.subjectHumansen
dc.subjectInflammationen
dc.subjectRheumatic Diseasesen
dc.subjectW.B. Saundersen
dc.titleRegulatory B cells: New players in inflammatory and autoimmune rheumatic diseasesen
dc.typeotheren


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής